Centogene B V Stock Today
| CNTG Stock | USD 0.09 0.01 16.88% |
Performance9 of 100
| Odds Of DistressOver 67
|
Centogene is trading at 0.09 as of the 28th of November 2024. This is a 16.88 percent up since the beginning of the trading day. The stock's lowest day price was 0.07. Centogene has more than 67 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Centogene B V are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of September 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 7th of November 2019 | Category Healthcare | Classification Health Care |
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany. The company has 29 M outstanding shares of which 81.71 K shares are currently shorted by private and institutional investors with about 0.82 trading days to cover. More on Centogene B V
Moving against Centogene Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Centogene Stock Highlights
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, Health Care, Health Care Providers & Services, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsCentogene can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Centogene's financial leverage. It provides some insight into what part of Centogene's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Centogene B V (CNTG) is traded on NASDAQ Exchange in USA and employs 384 people. Centogene is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.43 M. Centogene B V conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 29 M outstanding shares of which 81.71 K shares are currently shorted by private and institutional investors with about 0.82 trading days to cover.
Centogene B V currently holds about 42.67 M in cash with (36.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.58, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Centogene Probability Of Bankruptcy
Ownership AllocationCentogene holds a total of 29 Million outstanding shares. Over half of Centogene's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Centogene Ownership Details
Centogene Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Federation Des Caisses Desjardins Du Quebec | 2024-06-30 | 0.0 | |
| Junked Platinum Investment Management Ltd | 2024-06-30 | 0.0 | |
| Millennium Management Llc | 2024-06-30 | 0.0 | |
| Apollon Wealth Management, Llc | 2024-06-30 | 0.0 | |
| Scoggin Llc | 2024-06-30 | 0.0 | |
| Geode Capital Management, Llc | 2024-06-30 | 0.0 | |
| Meeder Asset Management Inc | 2024-06-30 | 0.0 | |
| Xtx Topco Ltd | 2024-09-30 | 0.0 | |
| Wells Fargo & Co | 2024-06-30 | 197.2 K | |
| Stifel Financial Corp | 2024-06-30 | 22.4 K | |
| Blackrock Inc | 2024-06-30 | 18.3 K |
Centogene B V Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Centogene market risk premium is the additional return an investor will receive from holding Centogene long position in a well-diversified portfolio.
| Mean Deviation | 24.19 | |||
| Semi Deviation | 21.16 | |||
| Standard Deviation | 40.9 | |||
| Variance | 1672.73 |
Centogene Stock Against Markets
Centogene Corporate Management
| Ian Rentsch | Chief Pharma | Profile | |
| Peter MD | Chief Officer | Profile | |
| Andrin MD | Advisor | Profile | |
| Kim Stratton | CEO Board | Profile | |
| Bettina Goerner | Chief Officer | Profile | |
| Lennart Streibel | Director Projects | Profile | |
| Florian Vogel | Chief Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centogene B V. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centogene. If investors know Centogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.39) | Revenue Per Share 1.723 | Quarterly Revenue Growth (0.08) | Return On Assets (0.27) | Return On Equity (13.75) |
The market value of Centogene B V is measured differently than its book value, which is the value of Centogene that is recorded on the company's balance sheet. Investors also form their own opinion of Centogene's value that differs from its market value or its book value, called intrinsic value, which is Centogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centogene's market value can be influenced by many factors that don't directly affect Centogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Centogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.